Navigation Links
Prodigy Diabetes Care, LLC Sponsors First 'Manufacturing Makes It Real Tour'
Date:9/29/2010

MT. HOLLY, N.C., Sept. 29 /PRNewswire/ -- Prodigy Diabetes Care, LLC, a high-tech manufacturer of blood glucose management supplies, is a proud bronze-level sponsor of the "Manufacturing Makes It Real Tour." Prodigy® participated in the rally at the Mt. Holly location of National Gypsum, a local manufacturer of wallboard and finishing products.  

Around noon, a busload of business and political leaders throughout North Carolina, along with a large variety of "Made in NC" products arrived at the Mt. Holly tour stop. Representatives from Prodigy® gave a speech before a room full of local manufacturers and government officials, which included Prodigy's future plans, upcoming product releases, and our devotion to North Carolina manufacturing.

The "Manufacturing Makes It Real Tour" is a week-long journey around the state to call attention to the high quality and competitive spirit of North Carolina manufacturers. The Industrial Extension Service at North Carolina State University is conducting the tour. All of the goods received by local manufacturers at each stop of the tour will be shown to Governor Perdue and state leaders, October 1st in Raleigh, NC. Governor Perdue recently proclaimed the week of September 27th-October 1st the "Manufacturing Makes it Real" week.  

Ramzi Abulhaj, President of Prodigy®, expressed his gratitude for the "Manufacturing Makes It Real Tour." "Events such as these truly recognize the efforts local businesses put forth to make manufacturing in America succeed. By bringing all of our operations to North Carolina, we are able to further expand our business and create jobs for North Carolina residents."

"It is admirable of Governor Perdue and the NC Department of Commerce to support the tour. By acknowledging  local companies, our state leaders have highlighted the importance of North Carolina manufacturing. Prodigy® is honored to have participated in the first 'Manufacturing Makes It Real Tour' and we look forward to next year's event," said Prodigy's Chief Operating Officer, Rick Admani Abulhaj.

Prodigy® manufactures diabetes management products which are made with a contemporary design, with a focus on the blind and low vision diabetic. The company has been headquartered in Charlotte, N.C. for over 4 years now, and has witnessed much success since this relocation. By undertaking multiple groundbreaking projects, Prodigy plans to create over 400 jobs in the next 3-5 years.

ABOUT PRODIGY® GLUCOSE MONITORING SYSTEMS

Prodigy® Meters are distributed by a privately owned company headquartered in Charlotte, NC, that develops, manufactures and markets technology-based diabetes products, with a focus on audible blood-glucose meters. The Prodigy® product line offers "talking" meters especially beneficial to the sight-impaired diabetic market. The Prodigy Voice® is the only meter for blind or low-vision diabetes patients to earn awards from both the National Federation of the Blind and the American Foundation for the Blind.  More information on Prodigy® can be found at www.prodigymeter.com

Contact: Anna Tucker, +1-704-247-8019, annat@prodigymeter.com


'/>"/>
SOURCE Prodigy Diabetes Care, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
2. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
3. The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management
4. Isis Initiates Phase 1 Study of ISIS 325568 Targeting Glucagon Receptor to Treat Type 2 Diabetes
5. Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells
6. Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure
7. ACTOS(R) (pioglitazone HCl) Demonstrates Reduced Risk of Ischemic Cardiovascular Disease in Patients with Type 2 Diabetes
8. Nastech Pharmaceutical Company Announces Initiation of Phase 2 Clinical Trial for Insulin Nasal Spray to Treat Diabetes
9. DiObex Begins Dosing Patients in Phase 2b Trial of Type 2 Diabetes Drug
10. Synvista Therapeutics Alagebrium Shows Potential for use in Treating Diabetes-Related Gastrointestinal Complications
11. Synvista Collaboration Demonstrates in Preclinical Studies the Mechanism for Defective Cholesterol Transport in Patients with Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... DALLAS , April 19, 2017 /PRNewswire/ ... that the first patients in Nashville ... in the Lower Esophageal Sphincter Stimulation for GERD (LESS ... device designed to provide long-term reflux control by restoring ... GERD affects nearly 65 million people in ...
(Date:4/19/2017)...  New research provides evidence that an old drug may ... study released today that will be presented at the ... Boston , April 22 to 28, 2017. ... disease, the oral drug levodopa has long been considered the ... the disease progresses, the effects of the medication can partially ...
(Date:4/18/2017)... Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical device ... markets with innovative and proprietary products, will release financial ... after the market close on Tuesday, May 2, 2017. ... call and webcast to discuss its financial results the ... p.m. Eastern Time (3:30 p.m. Central Time). Darin ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... April 25, 2017 , ... ProRehab Physical ... be the preferred physical therapy provider for Derby City CrossFit, effective immediately. , ... CrossFit as quickly and effectively as possible, ProRehab’s sports physical therapists will work ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... to compare student test score performance for the 2015-16 school year across Wisconsin’s ... voucher programs. Though it highlights important patterns in student test score performance, the ...
(Date:4/25/2017)... Switzerland (PRWEB) , ... April 25, 2017 , ... ... innovation targets, they rely on contracted partners to help with process innovation in ... of combined drug formulation experience along with state-of-the-art analytical equipment in support of ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to ... of acute or chronic problems, I focus on preventative care with all my patients to ... have any questions, always feel free to contact my office and my trained staff will ...
(Date:4/25/2017)... ... , ... Vetoquinol USA® , a world-class developer of ... the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in Lexington. Flexadin ... , The scientifically-developed Flexadin UCII supports the body’s normal repair of cartilage and ...
Breaking Medicine News(10 mins):